We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

GE Healthcare Launches Amersham™ Hyperfilm™ Blue for Autoradiography Screening Applications

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

GE Healthcare Life Sciences has extended its leading range of Amersham™ Hyperfilm™ products with Amersham Hyperfilm Blue, a blue sensitive film which enables rapid, qualitative results for the detection of chemiluminescent signals in different blotting assays.

The film requires minimal exposure time, often only one minute, to produce sharp and high contrast radiographs, making it ideal for use when experimental times need to be kept to a minimum.

Amersham Hyperfilm Blue, which provides a lower sensitivity than Amersham Hyperfilm, enables researchers to produce fast results in qualitative chemiluminescent detection in Western, Southern and Northern blots whilst reducing costs.

The film is compatible with a range of other GE Healthcare Life Sciences products including Amersham ECL™, Amersham ECL Prime, Amersham ECL Plus, Amersham ECL Advance™, CDP-Star™ and all blue and green chemiluminescence systems, and it can be processed in automatic processors or manually by using most common X-ray film developers and fixers.